EpiPen’s Steady Price Increases Masked Until Deductibles Rose
The maker of the life-saving allergy shot EpiPen is the new poster child for exorbitant drug price increases, as high-profile members of Congress, doctors and consumers lash out over huge price increases since 2009.
Mylan’s EpiPens are used to quickly treat the severe allergic reaction known as anaphylaxis, which can include swelling of the tongue or throat, shortness of breath and a rash.
The prices insurers and employers negotiate with Mylan are up about 150% since 2009, according to Rx Savings Solutions, which represents businesses and insurance companies. The average wholesale price has increased nearly 500% in that time, says Michael Rea, a pharmacist and CEO of Rx Savings Solutions.